Market Access

The medical device market access process in France is complex. There are many different funding schemes and pathways, derogatory or under common law, each involving multiple players in the healthcare system. Our firm, composed of 8 consultants, offers expertise and advice to manufacturers for the marketing of their health technologies, all along the pathway of the DM in France.

MedConsult’s consultants have acquired a solid experience in the market access of innovative DM and health technologies; with an incomparable track record of strategic analysis, submission of files for the LPPR, price negotiation and filing of new innovation financing processes (Forfait innovation, RIHN..)

All our activities

For all health products

Medical devices (DM)

  • Single use, implantable, capital equipment, etc
  • Therapeutic, Diagnostic or prognostic

In vitro diagnostic devices

  • Biological procedure acts,
  • Companion tests,
  • Capital equipment and consumables

And other innovative technologies

  • Connected medical devices or tele surveillance activities,
  • Foods for special medical purposes